Our study points to a strong association between UHRF1 and ALL, with UHRF1 as a regulator of c-Myc, CDK4/6, and Rb phosphorylation, and provides a rationale for the pursuit of UHRF1 as a potential therapeutic target in ALL. The gene discussed is UHRF1; the disease is acute lymphoblastic leukemia.